These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6339850)

  • 1. Immunobiologic staging of patients with carcinoma of the head and neck.
    Katz AE
    Laryngoscope; 1983 Apr; 93(4):445-63. PubMed ID: 6339850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic evaluation and prognosis in patients with head and neck cancer.
    Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
    Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic variables in head and neck cancer. Tumor site, stage, nodal status, differentiation, and immune status.
    Davis RK
    Otolaryngol Clin North Am; 1985 Aug; 18(3):411-9. PubMed ID: 4047665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunoglobulin E levels in patients with head and neck cancer.
    Lal H; Singh B; Wig U; Saini AS
    J Laryngol Otol; 1988 May; 102(5):432-4. PubMed ID: 3397638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulins in patients with carcinoma of the oral cavity, uterine cervix and breast.
    Vijayakumar T; Ankathil R; Remani P; Sasidharan VK; Vijayan KK; Vasudevan DM
    Cancer Immunol Immunother; 1986; 22(1):76-9. PubMed ID: 3708632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulin levels in patients with head and neck cancer (IgE, IgA, IgM, IgG).
    Vinzenz K; Pavelka R; Schönthal E; Zekert F
    Oncology; 1986; 43(5):316-22. PubMed ID: 3763126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
    Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
    J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunologic profile of young adults with head and neck cancer.
    Schantz SP; Liu FJ
    Cancer; 1989 Sep; 64(6):1232-7. PubMed ID: 2569924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
    Bier J; Nicklisch U
    Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the immunology of head and neck cancer--a prognostic index. Preliminary communication.
    Parker R; Alexander S; Shaheen OH; Parkes P
    J Laryngol Otol; 1975 Jul; 89(7):687-95. PubMed ID: 1185059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific immune determinants in the patient with unresectable gastrointestinal carcinoma.
    Moertel CG; Ritts RE; O'Connell MJ; Silvers A
    Cancer; 1979 Apr; 43(4):1483-92. PubMed ID: 376093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of patients with infectious forms of syphilis and changes in their immunological reactivity].
    Chistiakova AM; Reznikova LS
    Vestn Dermatol Venerol; 1975 Aug; (8):86-90. PubMed ID: 1101559
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis.
    Wolf GT; Schmaltz S; Hudson J; Robson H; Stackhouse T; Peterson KA; Poore JA; McClatchey KD
    Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1200-6. PubMed ID: 3499156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocompetence testing in patients with one of the four common operable cancers--a review.
    Wanebo HJ; Pinsky CM; Beattie EJ; Oettgen HF
    Clin Bull; 1978; 8(1):15-22. PubMed ID: 668106
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulins G, M, A, D and E in Behcet's syndrome.
    Scully C; Boyle P; Yap PL
    Clin Chim Acta; 1982 Apr; 120(2):237-42. PubMed ID: 7067147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
    Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic determinants of head and neck cancer response to induction chemotherapy.
    Schantz SP; Savage HE; Racz T; Liu FJ; Brown BW; Rossen RD; Hong WK
    J Clin Oncol; 1989 Jul; 7(7):857-64. PubMed ID: 2472470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential evaluation of immunoreactivity in patients with melanoma undergoing surgery and adjuvant therapy.
    Dionigi R; Dominioni L; Gnes F; Bonera A; Prati U; Scarponi A; Robustelli Della Cuna G; Pavesi L; Campani M
    Tumori; 1980 Feb; 66(1):59-76. PubMed ID: 6966434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major immunoglobulin ratios in carcinoma of the head and neck.
    Katz AE; Nysather JO; Harker LA
    Ann Otol Rhinol Laryngol; 1978; 87(3 Pt 1):412-5. PubMed ID: 655583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.